home.aspx
 
EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...

Asklepios

SHARESHARESHARE
Asklepios is a privately held hospital group founded by Dr. gr. Broermann in 1984. It is now operating more than 100 hospitals mainly based in Germany and generating a revenue of 2.3 billion €, making it the largest hospital group in Europe. With its Asklepios Future Hospital Program it initiated an R&D innovation program that is one of it's kind, partnering with 27 industry partners including Intel, Microsoft, Siemens and SAP.
SHARESHARESHARE

RELATED NEWS


A leading respiratory physician has welcomed the new PBS listing for omalizumab (Xolair) which will give children from six years access to the drug for severe allergic asthma. The therapy was......
PHARMACYNEWS.COM
READ MORE

The report, released by UK industry group the BioIndustry Association (BIA) and Informa Pharma Intelligence, shows that the UK held the largest number of clinical trials in Europe in 2017, with 351 pre-clinical trials, 43 in Phase I, 70 in Phase II, and 15 in Phase III. The next highest, France, held 192 pre-clinical trials. Some of the strength of the pipeline can be attributed to the significant amount of funding that the UK invests in early stage and translational science, the report noted. A...

READ MORE

An allergic reaction of any kind is a result of the immune system responding to an otherwise harmless allergen as if it were a pathogen. However, sending the right messages to the immune system can change the way it operates, as Duke University scientists found in their new study aimed at reducing the severity of food allergies....
LABROOT
READ MORE

Rising Pharma Holdings, Inc., f. k. a. Shore Suven Pharma, Inc., announced today that it completed the purchase of the assets of Rising Pharmaceuticals and Rising’s subsidiaries on a cash-free and debt-free basis. Shore Suven Pharma, Inc., created as an acquisition entity to acquire the assets and affiliates of Rising Pharmaceuticals, Inc. will hereafter be called, Rising Pharma Holdings, Inc. Rising Pharmaceuticals will continue to operate seamlessly and transact all business under the Ri...

READ MORE

Johnson & Johnson’s share price took a beating this week after the US appeals court declined its bid to stop sales of cheap generic versions of its blockbuster prostate cancer drug Zytiga. The company’s shares fell around 3% because of the court decision relating to Zytiga (abiraterone), which is the biggest-selling oncology drug from J&J’s pharma unit Janssen. In the third quarter alone Zytiga generated US sales of $527 million and the company is fighting hard to preve...

READ MORE

Merck’s vaunted PD-1 inhibitor Keytruda took a stumble in a late-stage trial as a treatment of patients with advanced hepatocellular carcinoma (HCC) who were previously treated with systemic therapy. In the pivotal Phase, III KEYNOTE-240 trial, Keytruda plus best supportive care failed to hit endpoints in both overall survival and progression-free survival in comparison to placebo and best supportive care. Merck said in the final analysis of the KEYNOTE-240 data there was some improvement ...

READ MORE

EVENTS

THE 2021 CLINICAL DISCLOSURE VIRTUAL
THE 2021 CLINICAL DISCLOSURE VIRTUAL
May 11-12, 2021
Sophisticated and fully interactive conference experience, leverage best practices, networking and on-demand sessions will be available in one place, at the touch of a button.

Discover how Clinical Data Disclosure, Transparency & Plain Language Summaries Virtual Platform will elev...

Pharma Manufacturing Automation 2021
PHARMA MANUFACTURING AUTOMATION 2021
May 18-19, 2021
As the use of the robotics in the pharmaceutical manufacturing industry increases rapidly, it’s important to consider the benefits of the latest technologies for manufacturers, researchers and scientists. The advantages include greater speed and accuracy, more flexibility and more reliability ...